IRIDEX Cash on Hand 2010-2024 | IRIX
IRIDEX cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
IRIDEX Annual Cash on Hand (Millions of US $) |
2023 |
$7 |
2022 |
$14 |
2021 |
$24 |
2020 |
$12 |
2019 |
$13 |
2018 |
$21 |
2017 |
$22 |
2016 |
$24 |
2015 |
$10 |
2014 |
$13 |
2013 |
$13 |
2012 |
$12 |
2011 |
$11 |
2010 |
$8 |
2009 |
$9 |
IRIDEX Quarterly Cash on Hand (Millions of US $) |
2024-09-30 |
$4 |
2024-06-30 |
$4 |
2024-03-31 |
$5 |
2023-12-31 |
$7 |
2023-09-30 |
$8 |
2023-06-30 |
$10 |
2023-03-31 |
$11 |
2022-12-31 |
$14 |
2022-09-30 |
$16 |
2022-06-30 |
$18 |
2022-03-31 |
$21 |
2021-12-31 |
$24 |
2021-09-30 |
$26 |
2021-06-30 |
$26 |
2021-03-31 |
$28 |
2020-12-31 |
$12 |
2020-09-30 |
$12 |
2020-06-30 |
$12 |
2020-03-31 |
$11 |
2019-12-31 |
$13 |
2019-09-30 |
$13 |
2019-06-30 |
$16 |
2019-03-31 |
$17 |
2018-12-31 |
$21 |
2018-09-30 |
$24 |
2018-06-30 |
$16 |
2018-03-31 |
$19 |
2017-12-31 |
$22 |
2017-09-30 |
$23 |
2017-06-30 |
$25 |
2017-03-31 |
$24 |
2016-12-31 |
$24 |
2016-09-30 |
$10 |
2016-06-30 |
$12 |
2016-03-31 |
$11 |
2015-12-31 |
$10 |
2015-09-30 |
$10 |
2015-06-30 |
$12 |
2015-03-31 |
$13 |
2014-12-31 |
$13 |
2014-09-30 |
$13 |
2014-06-30 |
$13 |
2014-03-31 |
$14 |
2013-12-31 |
$13 |
2013-09-30 |
$14 |
2013-06-30 |
$14 |
2013-03-31 |
$12 |
2012-12-31 |
$12 |
2012-09-30 |
$14 |
2012-06-30 |
$14 |
2012-03-31 |
$14 |
2011-12-31 |
$11 |
2011-09-30 |
$10 |
2011-06-30 |
$9 |
2011-03-31 |
$9 |
2010-12-31 |
$8 |
2010-09-30 |
$7 |
2010-06-30 |
$7 |
2010-03-31 |
$6 |
2009-12-31 |
$9 |
2009-09-30 |
$8 |
2009-06-30 |
$7 |
2009-03-31 |
$6 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|